Engineering nanoparticles to overcome the mucus barrier for drug delivery: design, evaluation and state-of-the-art
[DOI] [PMC free article] [PubMed] [Google Scholar] 135.Pittaluga E., Costa G., Krasnowska E., Brunelli R., Lundeberg T., Porpora M.G., Santucci D., Parasassi T
10.2174/1389450118666170613081730 111 SeneschalJ.BonifaceK.DArinoA.PicardoM
This muscle-sparing effect distinguishes it from many other fat loss approaches including some GLP-1 medications and severe caloric restriction
Furthermore, the peptide has no effect on speeding up recovery in patients with hip fractures
Accordingly, the global distributions of phases (Figure 3C) and amplitudes (Figure 3D) of rhythmic metabolites were highly similar between controls and cKOt